Biotech

All Articles

Amgen files very first period 3 win for $400M chronic eczema drug

.Amgen has actually discussed (PDF) the 1st period 3 records on its own $400 thousand chronic eczema...

Biogen, UCB document phase 3 lupus gain after stopping working earlier test

.Biogen and UCB's rely on advancing into phase 3 astride a broken study hopes to have actually paid ...

Aptadir wishes new RNA preventions can easily reverse difficult cancers

.Italian biotech Aptadir Therapies has actually launched with the guarantee that its pipe of preclin...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending out stockpile

.Surge Lifestyle Sciences has actually satisfied its own goal in a Duchenne muscle dystrophy (DMD) r...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupy...

Achilles droplets cell therapy system, braces for cutbacks after missing 'business stability' objectives

.Achilles Rehabs has actually torn up its technique. The British biotech is quiting working on its o...

Aligos heralds phase 2 MASH gain, reducing liver body fat around 46%

.Aligos Rehabs is actually proclaiming a midstage win in metabolic-dysfunction linked steatohepatiti...

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job developing brand-new antifungals has actually obtained a significant bo...

Capricor offers Europe legal rights to late-stage DMD treatment for $35M

.Having currently scooped up the USA civil rights to Capricor Therapeutics' late-stage Duchenne musc...

FDA fragments adcomm for Applied's unusual illness drug

.After dismissing the choice meeting for Applied Therapies' metabolic ailment drug govorestat, the F...